IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
PremiumPress ReleasesIRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
3M ago
iRadimed sees 2024 adjusted EPS $1.52-$1.62
PremiumThe Fly
iRadimed sees 2024 adjusted EPS $1.52-$1.62
3M ago
iRadimed sees Q2 adjusted EPS 36c-39c
PremiumThe Fly
iRadimed sees Q2 adjusted EPS 36c-39c
3M ago
iRadimed sees Q1 adjusted EPS 33c-35c, consensus 41c
PremiumThe FlyiRadimed sees Q1 adjusted EPS 33c-35c, consensus 41c
6M ago
iRadimed sees FY24 adjusted EPS $1.52-$1.62, consensus $1.67
PremiumThe Fly
iRadimed sees FY24 adjusted EPS $1.52-$1.62, consensus $1.67
6M ago
iRadimed reports Q4 adjusted EPS 39c, consensus 40c
PremiumThe Fly
iRadimed reports Q4 adjusted EPS 39c, consensus 40c
6M ago
iRadimed reports preliminary Q4 revenue $17.5M, consensus $17.13M
PremiumThe FlyiRadimed reports preliminary Q4 revenue $17.5M, consensus $17.13M
7M ago
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
7M ago
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
PremiumPress Releases
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100